News & Updates

In the highly regulated pharmaceutical industry, ensuring compliance with evolving guidelines is critical to maintaining product quality, patient safety, and operational efficiency.

To improve efficiency, reduce costs, and bring high-quality therapies to patients faster, Vilintra is implementing the ICH M13 Guidelines.

The pharmaceutical industry continues to evolve rapidly, driven by increasing complexity in clinical trials and stringent regulatory demands.

GAMP® 5 (Good Automated Manufacturing Practice) is a globally recognized guideline for ensuring the quality, reliability, and compliance of automated systems in regulated industries like pharmaceuticals.

Clinical trials play a vital role in advancing every aspect of discovery and innovation in science. Researchers often encounter significant challenges and a 2018 article revealed that more than half of phase 3 trial failures stem from issues such as flawed design and unsuitable statistical objectives.